"UPMC Hillman Cancer Center - Harrisburg (Radiation Oncology) is a Cancer treatment center located in Harrisburg.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, PinnacleHealth Regional Cancer Center at Polyclinic Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PinnacleHealth Regional Cancer Center at Polyclinic Hospital" #1 sponsor was "NSABP Foundation Inc" with 4 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Eastern Cooperative Oncology Group" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PinnacleHealth Regional Cancer Center at Polyclinic Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "PinnacleHealth Regional Cancer Center at Polyclinic Hospital" are "Lung Cancer" (6 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Kidney Cancer" (2 trials) and "Adenocarcinoma of the Colon" (1 trials). Many other conditions were trialed in "PinnacleHealth Regional Cancer Center at Polyclinic Hospital" in a lesser frequency.

Most popular intervention types in "PinnacleHealth Regional Cancer Center at Polyclinic Hospital" are "Drug" (14 trials), "Biological" (6 trials), "Other" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (4 trials), "carboplatin" (3 trials), "cyclophosphamide" (3 trials), "irinotecan hydrochloride" (3 trials) and "bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "PinnacleHealth Regional Cancer Center at Polyclinic Hospital" are 14 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "PinnacleHealth Regional Cancer Center at Polyclinic Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in PinnacleHealth Regional Cancer Center at Polyclinic Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in PinnacleHealth Regional Cancer Center at Polyclinic Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".